309 related articles for article (PubMed ID: 33328401)
1. Borderline Case of TAFRO Syndrome and POEMS Syndrome.
Shibata S; Tabata S; Morita H; Endo T; Kawasaki N; Okamoto Y; Inano S; Takiuchi Y; Fukunaga A; Kitano T
Intern Med; 2021 May; 60(10):1589-1595. PubMed ID: 33328401
[TBL] [Abstract][Full Text] [Related]
2. Tufted-angioma-like lesion associated with vascular endothelial growth factor and interleukin-6 in TAFRO syndrome: Is it a common histological feature of multicentric Castleman disease/POEMS syndrome?
Fujita K; Hatta K
J Cutan Pathol; 2019 Apr; 46(4):280-284. PubMed ID: 30632181
[TBL] [Abstract][Full Text] [Related]
3. Castleman disease and TAFRO syndrome.
Masaki Y; Arita K; Sakai T; Takai K; Aoki S; Kawabata H
Ann Hematol; 2022 Mar; 101(3):485-490. PubMed ID: 35044513
[TBL] [Abstract][Full Text] [Related]
4. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
[TBL] [Abstract][Full Text] [Related]
5. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Takai K; Aoki S; Kuroda J; Ide M; Setoguchi K; Tsukamoto N; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Masaki Y
Am J Hematol; 2019 Sep; 94(9):975-983. PubMed ID: 31222819
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of Castleman Disease.
Szalat R; Munshi NC
Hematol Oncol Clin North Am; 2018 Feb; 32(1):53-64. PubMed ID: 29157619
[TBL] [Abstract][Full Text] [Related]
7. Historical and pathological overview of Castleman disease.
Nishimura MF; Nishimura Y; Nishikori A; Yoshino T; Sato Y
J Clin Exp Hematop; 2022 Jun; 62(2):60-72. PubMed ID: 35474035
[TBL] [Abstract][Full Text] [Related]
8. TAFRO Syndrome: A Disease Requiring Immediate Medical Attention.
Masaki Y; Ueda Y; Yanagisawa H; Arita K; Sakai T; Yamada K; Mizuta S; Fukushima T; Takai K; Aoki S; Kawabata H
Intern Med; 2023 Jan; 62(1):27-32. PubMed ID: 35598998
[TBL] [Abstract][Full Text] [Related]
9. The clinical spectrum of Castleman's disease.
Dispenzieri A; Armitage JO; Loe MJ; Geyer SM; Allred J; Camoriano JK; Menke DM; Weisenburger DD; Ristow K; Dogan A; Habermann TM
Am J Hematol; 2012 Nov; 87(11):997-1002. PubMed ID: 22791417
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome.
Iwaki N; Gion Y; Kondo E; Kawano M; Masunari T; Moro H; Nikkuni K; Takai K; Hagihara M; Hashimoto Y; Yokota K; Okamoto M; Nakao S; Yoshino T; Sato Y
Sci Rep; 2017 Feb; 7():42316. PubMed ID: 28205564
[TBL] [Abstract][Full Text] [Related]
11. Glomeruloid hemangioma associated with TAFRO syndrome.
Shinozaki-Ushiku A; Higashihara T; Ikemura M; Sato J; Nangaku M; Ushiku T; Fukayama M
Hum Pathol; 2018 Dec; 82():172-176. PubMed ID: 29702119
[TBL] [Abstract][Full Text] [Related]
12. Case report: Castleman disease in association with POEMS.
Adelman HM; Cacciatore ML; Pascual JF; Mike JM; Alberts WM; Wallach PM
Am J Med Sci; 1994 Feb; 307(2):112-4. PubMed ID: 8141136
[TBL] [Abstract][Full Text] [Related]
13. Subclinical Hypothyroidism in TAFRO Syndrome.
Oka S; Ono K; Nohgawa M
Intern Med; 2019 Sep; 58(18):2615-2620. PubMed ID: 31178506
[TBL] [Abstract][Full Text] [Related]
14. TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities.
Tu KH; Fan PY; Chen TD; Chuang WY; Wu CY; Ku CL; Tian YC; Yang CW; Fang JT; Yang HY
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208103
[TBL] [Abstract][Full Text] [Related]
15. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome.
D'Souza A; Hayman SR; Buadi F; Mauermann M; Lacy MQ; Gertz MA; Kyle RA; Kumar S; Greipp PR; Lust JA; Russell SJ; Zeldenrust S; Dingli D; Witzig TE; Rajkumar SV; Dispenzieri A
Blood; 2011 Oct; 118(17):4663-5. PubMed ID: 21881050
[TBL] [Abstract][Full Text] [Related]
16. Castleman disease of the hyaline vascular variant transforming to POEMS syndrome as endpoint: a case report.
Ge Y; Da Q; Dai Y
BMC Neurol; 2018 Oct; 18(1):169. PubMed ID: 30301456
[TBL] [Abstract][Full Text] [Related]
17. [Incomplete POEMS syndrome with multicentric Castleman's disease].
González de la Aleja P; García-Navarro M; Sánchez-Martínez R; Ramos JM
An Sist Sanit Navar; 2017 Dec; 40(3):475-478. PubMed ID: 28906499
[TBL] [Abstract][Full Text] [Related]
18. Treatment response and prognosis of POEMS syndrome coexisting with Castleman disease.
Suichi T; Misawa S; Sekiguchi Y; Shibuya K; Tsuneyama A; Suzuki YI; Nakamura K; Kano H; Kuwabara S
J Neurol Sci; 2020 Jun; 413():116771. PubMed ID: 32172013
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary and Pancreatic: Obliterative portal venopathy found in Castleman disease variant of POEMS syndrome.
Zhang L; Gao H; Feng Y; Wang G; Zhang X; Li Z
J Gastroenterol Hepatol; 2018 Jul; 33(7):1311. PubMed ID: 29691905
[No Abstract] [Full Text] [Related]
20. Clinical spectrum of Castleman disease-associated neuropathy.
Naddaf E; Dispenzieri A; Mandrekar J; Mauermann ML
Neurology; 2016 Dec; 87(23):2457-2462. PubMed ID: 27807187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]